Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07361887 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.

Study acronym: (WINEVOME)
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
University of Seville
44 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
Dementia
1,978 trials monitored
See 106 trials at risk
and 1 more disease
This study aims to investigate how moderate wine consumption influences circulating extracellular vesicles (EVs) in healthy adults. EVs are small particles released by cells that carry proteins, lipids, and genetic material, and play important roles in communication between cells. Participants will consume a single serving of red or white wine, and blood samples will be collected before and after consumption to study changes in the composition and function of EVs. The study will also assess how these EVs affect vascular, immune, and brain-related cells. The results are expected to improve our understanding of how moderate wine intake contributes to cardiovascular and brain health.
Trial Details
NCT Number NCT07361887
Lead Sponsor University of Seville
Conditions
(from sponsor)		 Atherosclerosis Cardiovascular Disease, Obesity, Metabolic Syndrome, Metabolic Disorders, Inflammation, Neurodegeneration, Neurodegenerative Disease, Alzheimer s Disease
Related terms Inflammation, Metabolic Diseases, Metabolic Syndrome, Nerve Degeneration, Neurodegenerative Diseases, Obesity, Vascular Diseases
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov